(Total Views: 694)
Posted On: 07/28/2020 7:28:03 AM
Post# of 153908
I don’t think the directors of Cytodyn are going to change management in response to anything posted by any of us on any board.
As with so much that has transpired with this company and the larger response to Covid, we should all take a small step back and be patient.
We all have different perspectives and I fear losing valuable perspectives because we don’t appreciate one line of thought regarding one aspect of leronlimab, Cytodyn, it’s strategy and its tactics.
Dr. Pourhassan has been incredibly successful resuscitating Cytodyn, and by his actions, potentially saving many millions of lives.
Nonetheless, that does not mean he is the right person to continue as CEO perpetually.
At some point Dr. Pourhassan will want to step back and admire what he has created or his board will decide someone else should take the helm.
Not my or our decision.
I just believe it is unfair to excoriate someone who makes that suggestion based on his (apparent) experience at the upper levels of the pharmaceutical industry.
As with so much that has transpired with this company and the larger response to Covid, we should all take a small step back and be patient.
We all have different perspectives and I fear losing valuable perspectives because we don’t appreciate one line of thought regarding one aspect of leronlimab, Cytodyn, it’s strategy and its tactics.
Dr. Pourhassan has been incredibly successful resuscitating Cytodyn, and by his actions, potentially saving many millions of lives.
Nonetheless, that does not mean he is the right person to continue as CEO perpetually.
At some point Dr. Pourhassan will want to step back and admire what he has created or his board will decide someone else should take the helm.
Not my or our decision.
I just believe it is unfair to excoriate someone who makes that suggestion based on his (apparent) experience at the upper levels of the pharmaceutical industry.
(2)
(2)
